HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,894 | +3.2% | 32,301 | -2.0% | 0.02% | +8.7% |
| Q2 2023 | $2,805 | +0.5% | 32,944 | -2.4% | 0.02% | -4.2% |
| Q1 2023 | $2,792 | -0.9% | 33,737 | -5.8% | 0.02% | -4.0% |
| Q4 2022 | $2,816 | -99.9% | 35,801 | +0.6% | 0.02% | 0.0% |
| Q3 2022 | $2,634,000 | +16.6% | 35,575 | +2.6% | 0.02% | +19.0% |
| Q2 2022 | $2,259,000 | +5.3% | 34,659 | +2.1% | 0.02% | +23.5% |
| Q1 2022 | $2,146,000 | -43.1% | 33,943 | -52.3% | 0.02% | +21.4% |
| Q4 2021 | $3,770,000 | +51.2% | 71,092 | +101.2% | 0.01% | -33.3% |
| Q3 2021 | $2,494,000 | -4.3% | 35,327 | -9.7% | 0.02% | 0.0% |
| Q2 2021 | $2,607,000 | +145.0% | 39,120 | +308.0% | 0.02% | -47.5% |
| Q1 2021 | $1,064,000 | -12.6% | 9,589 | -6.5% | 0.04% | -13.0% |
| Q4 2020 | $1,218,000 | +36.5% | 10,259 | +0.4% | 0.05% | +17.9% |
| Q3 2020 | $892,000 | -5.2% | 10,223 | -2.7% | 0.04% | -11.4% |
| Q2 2020 | $941,000 | -1.8% | 10,506 | +9.2% | 0.04% | +91.3% |
| Q1 2020 | $958,000 | -17.8% | 9,617 | -5.2% | 0.02% | +9.5% |
| Q4 2019 | $1,166,000 | -3.0% | 10,147 | +6.5% | 0.02% | -16.0% |
| Q3 2019 | $1,202,000 | +3.3% | 9,528 | -1.5% | 0.02% | -7.4% |
| Q2 2019 | $1,164,000 | +60.8% | 9,674 | +16.8% | 0.03% | +50.0% |
| Q1 2019 | $724,000 | -10.8% | 8,281 | +2.0% | 0.02% | -21.7% |
| Q4 2018 | $812,000 | +98.0% | 8,117 | +126.6% | 0.02% | +130.0% |
| Q3 2018 | $410,000 | -47.8% | 3,582 | -59.1% | 0.01% | -47.4% |
| Q2 2018 | $785,000 | +39.2% | 8,757 | +13.6% | 0.02% | +26.7% |
| Q1 2018 | $564,000 | +25.3% | 7,711 | -0.5% | 0.02% | +25.0% |
| Q4 2017 | $450,000 | +39.8% | 7,752 | +8.1% | 0.01% | +20.0% |
| Q3 2017 | $322,000 | +11.4% | 7,172 | -2.0% | 0.01% | +11.1% |
| Q2 2017 | $289,000 | +2.8% | 7,322 | +5.7% | 0.01% | -35.7% |
| Q1 2017 | $281,000 | +1.1% | 6,930 | +0.1% | 0.01% | +7.7% |
| Q4 2016 | $278,000 | +25.8% | 6,923 | +13.5% | 0.01% | 0.0% |
| Q3 2016 | $221,000 | +0.9% | 6,101 | +0.2% | 0.01% | 0.0% |
| Q2 2016 | $219,000 | -0.9% | 6,088 | +14.0% | 0.01% | -40.9% |
| Q2 2015 | $221,000 | -0.9% | 5,341 | +0.9% | 0.02% | -42.1% |
| Q4 2013 | $223,000 | – | 5,295 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |